Autres langues BeyondSpring Inc.

Actions

BYSI

KYG108301006

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 26/06/2024			Varia. 5j.	Varia. 1 janv.
2,44 ^USD	+3,39%		-14,08%	+171,11%

21/05	Les plus fortes baisses du prémarché	MT
15/05	Transcript : BeyondSpring Inc. - Special Call

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

BeyondSpring Raises $3 Million via Stock Sale	12/06
BeyondSpring : Securities Purchase Agreement Form 6 K	12/06
Top Premarket Decliners	21/05
BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics	16/05
BEYONDSPRING TO HOST VIRTUAL R&D DAY TO DISCUSS NEW PLINABULIN DEVELOPMENT STRATEGY FOR CANCER AND UPDATES FOR SEED THERAPEUTICS	06/05
BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics	03/05
BeyondSpring Files 2023 Annual Report on Form 20-F	29/04
BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results	29/04
BeyondSpring Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/04
North American Morning Briefing : Investors Brace -2-	29/04
North American Morning Briefing : Stock Futures -2-	22/04
North American Morning Briefing : Stock Futures -2-	15/04
BeyondSpring Says First Patient Dosed in Phase 2 Trial of Lung Cancer Combination Treatment	25/03
BeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer	25/03
Beyondspring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in A Phase 2 Investigator-Initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer	25/03
BeyondSpring Inc. Announces Executive Changes	18/03
Top Premarket Decliners	06/03
BeyondSpring Regains Compliance with Nasdaq Minimum Bid Price and Periodic Filing Requirements	26/02
BeyondSpring Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	02/02
BeyondSpring Receives Non-Compliance Notice From Nasdaq	10/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues BeyondSpring Inc.

Actions

BYSI

KYG108301006

Autres langues

Filtres